Where this stands — as at 8 September 2026
This piece was published on 1 September 2026 and has been updated twice and corrected once. The full revision history is at the foot of the page; nothing has been removed. This summary is the current position.
What happened. On 28 August, Cardiff and Vale University Health Board announced that the NHS Wales Joint Commissioning Committee had asked it to pause referrals for gender affirming surgery, surgical assessments, and operations already scheduled. The decision was taken on 24 August, when the service was escalated to Level 3 of the commissioner’s escalation framework. Some patients learned of the cancellation hours beforehand; some had already been admitted.
What the commissioner has said since. On 4 September, after meeting the health minister and deputy first minister, it set out its reasoning: a significantly higher referral rate than England; a significantly lower proportion of Welsh patients progressing from referral to surgery for some procedures; cases in which patients did not meet the basic requirements for surgery, with body mass index arising as a factor; concerns about whether wider health needs had been considered; and concerns raised by some clinical professionals about parts of the referral assessment process.
What is not disputed here. If the commissioner holds a specific documented concern that individual referrals were made without adequate clinical assessment, a pause may have been necessary and right. Nothing below claims otherwise.
What the pause does not affect. People progressing through a planned series of procedures as part of a transition pathway, people needing treatment for complications, and people who have begun a series and need clinically necessary aftercare. On resumption, people will be considered in the order they held on the surgery waiting list. Both points came from the commissioner via Llais and neither was in the original announcement.
What the published record still does not contain. The decision itself. The authority under which the pause was imposed. Any equality impact assessment. The paper before the sub-committee on 24 August recommended only that members take assurance and proposed no pause; the escalation framework places measures that stop service delivery at Level 4, and the service was placed at Level 3; and the paper records that neither a Quality nor an Equality Impact Assessment screening was undertaken.
On the review the pause defers to. As at 8 September, its scope exists only in initial indicative form and has yet to be shaped with the expert review team. Llais, the statutory body representing people who use NHS Wales services, has not been given the terms of reference and was not given the scope. The commissioner’s paper of 24 August states the review will focus primarily on assessment, referral and non-surgical aspects of the pathway.
On patient representation. Llais said on 3 September that it first became aware of the change when it was publicly announced, did not see the information that led to it, and would have expected earlier engagement as the independent body representing people who use NHS Wales services. It has confirmed it was formally notified on 1 September and had no role in the decision-making process.
Our position in this. On 1 September we put eleven questions to the commissioner, including the decision record, the authority relied upon, and whether an equality impact assessment was undertaken. No response has been received. We have also written to Llais, and made submissions to two Senedd committees proposing that commissioning oversight and equality impact assessment in commissioning decisions be examined. We are a party to this, not a neutral observer, and readers should weigh what follows accordingly.
Note on structure, 8 September 2026. This piece had accumulated three dated panels above the text, which made it hard to enter. The summary above now carries the current position, and the three panels have been moved unchanged to a revision history at the foot of the page. Nothing has been deleted and no wording has been altered, with one exception recorded in the revision history.
On 28 August 2026, Cardiff and Vale University Health Board announced that the NHS Wales Joint Commissioning Committee had asked it to pause referrals for gender affirming surgery through the Welsh Gender Service, together with surgical assessments and operations that had already been scheduled. Patients have reported learning that their surgery was cancelled days, and in some cases hours, beforehand. Some had already been admitted.
I want to be careful about what I am saying here, because the temptation to say more than the evidence supports is strongest exactly when something feels this wrong.
What I am not claiming
I am not claiming the pause is unjustified. I do not know whether it is, and neither does anyone else writing about it this week.
There is a version of this decision that is not merely defensible but obligatory. If the commissioner holds a specific, documented concern that individual referrals were made without adequate clinical assessment, then allowing irreversible surgery to proceed on those referrals while the question is open would be indefensible. On that reading the pause is the only responsible action available, and every procedural objection to it is a technicality.
There are also real governance problems here that have nothing to do with anyone’s politics. Freedom of information responses established earlier this year that the Welsh Gender Service does not know what proportion of its intake it passes to local gender teams for hormone prescribing, and that its own conversion data was manually tracked and described by the health board as not reliable. That is a genuine deficiency. And an independent review of the service was agreed in July 2024, had an executive lead appointed in September 2024 who resigned in February 2025, and still had no finalised scope by March 2026. Two years of drift makes an abrupt intervention in 2026 more explicable, not less.
None of that is a defence of the service. It is the reason I am asking questions rather than making accusations.
What the published record actually contains
Three documents matter, and all three are the commissioner’s own.
The paper that went to the committee. Agenda Item 3.4 was before the Quality, Safety and Outcomes Sub-Committee on 24 August. It describes the Welsh Gender Service as under consideration as a potential Service of Concern. It records that enhanced governance arrangements were being considered. Its sole recommendation to members is that they take assurance. It does not propose pausing anything.
The same paper states that the independent review will focus primarily on assessment, referral and non-surgical aspects of the pathway, with initial findings expected in the second half of 2026. It records that the activity analysis with NHS England’s referral support service — the analysis that would test the referral-rate concern — was still in progress. And its impact assessment boxes record that neither a Quality Impact Assessment screening nor an Equality Impact Assessment screening was undertaken.
The escalation framework. The commissioner publishes it. Level 3, the level the service was placed at, consists of a formal paper to the Corporate Directors Group, a nominated executive lead, written notification to the provider, monthly executive-led meetings, agreed objectives and timelines, and risk register entry. Measures that stop or redirect delivery to patients — decommissioning, temporary or permanent outsourcing, contractual realignment — appear at Level 4, which additionally requires the involvement of the Managing Director, the provider’s chief executive, and Welsh Government.
What Level 3 has meant elsewhere. Cardiff and Vale’s Neonatal Intensive Care Unit has been at Level 3 since September 2023 over cot closures and infection rates; the service was not suspended. The Salford obesity surgery service was escalated to Level 3 in January 2025 over waiting list and activity levels; when the provider then served notice, the commissioner’s recorded priority was ensuring that patients already on the waiting list were not adversely affected. Neither of those is a perfect comparison — neither concerned whether the right patients were being referred — but they show what this framework has meant in practice for other services.
The referral rate cannot carry the weight placed on it
The stated trigger is that Wales refers for gender surgery at a higher rate per head of population than England.
A rate is not a measure of clinical appropriateness. It is a composite of at least four things: how many people reach the referral point in a given year, which depends heavily on how long the local waiting list is; how the service is configured, since the Welsh service assesses and refers outward while English services do more in-house; cross-border flow; and any genuine difference in assessment threshold. A service that has worked through a backlog produces a referral spike that says nothing whatever about whether individual decisions were sound.
The comparator compounds this. English gender services have waiting times measured in years. A referral rate suppressed by a queue is a measure of throughput, not a standard of care. Comparing against it without saying so treats a capacity constraint as a clinical benchmark.
This cuts both ways, and I want to be explicit about that: the same reasoning means the rate cannot be used to exonerate the service either. Only case-level review of whether referrals were supported by documented assessment can answer the question. That is what the independent review is nominally for — and it is being conducted after the pause rather than before it.
What we have done
Before publishing this, I wrote to the NHS Wales Joint Commissioning Committee governance team, copied to the commissioning directorate responsible for the service and to Cardiff and Vale, asking eleven questions. Every one of them rests on documents the commissioner has itself published. No deadline was set and no reply has yet been due.
They include: the decision record for the pause and the authority under which it was taken; the escalation history of the service; whether an Equality Impact Assessment was undertaken for the decision; the numerator, denominator and comparator definitions behind the referral-rate finding, and whether that analysis was complete when the decision was made; and, most importantly, whether there is a specific documented concern about the adequacy of individual clinical assessments, as distinct from the aggregate rate comparison.
That last question is not rhetorical. If the answer is yes, the pause is justified and much of what I have written above becomes a procedural quibble about a decision that was substantively right. I would rather find that out than be right about the framework.
[Superseded, 5 September 2026. The commissioner has now answered this publicly, and the answer is yes: it has stated specific concerns about whether patients met the basic requirements for surgery and whether parts of the assessment process were carried out appropriately. See the revision history.]
We will publish the response when it comes, in full, and we will record its absence if it does not. This piece will carry an update either way.
Why this matters beyond Wales
The pattern is one I have written about before in a different context: a decision taken on the strength of an aggregate comparison whose confounders were never characterised, with the analysis that would test it still in progress, and with the review it defers to not yet begun. Whether or not the conclusion turns out to be correct, that sequence is not how a safety case is built. It is how a safety case is announced.
People had operations cancelled while already in hospital. If the reason was sound, they are owed the reason. If it was not, they are owed rather more than that.
[Partly superseded, 5 September 2026. The reason has since been given, four days after this was written and a week after the cancellations. The question of why it was not given at the time, and of what was recorded when the decision was taken, remains.]
Revision history
Newest first. Panels are reproduced as published, with one wording correction noted at the end.
Correction — 8 September 2026
The update below, published on 7 September, stated that Llais had been given an outline of the independent review’s proposed scope. That was wrong, and we are grateful to Llais for correcting it.
Llais has since checked its records and confirmed that the commissioner did not share the scope of this review with it at all. The earlier answer had conflated this review with others for which scope had been shared. Llais holds nothing on the scope of this review.
The commissioner has told Llais that it has developed an initial indicative scope, but that this will need to be further shaped and refined with support from the expert review team to ensure the process is thorough and robust.
The error originated in information given to us in good faith and corrected promptly and unprompted. It appeared in something we published, so it is corrected here on the same terms as any other error. The original wording is marked below rather than removed.
Update — 7 September 2026
Llais, the statutory body representing people who use NHS Wales services, issued a statement on 3 September and has since answered questions we put to it directly. Together these add several facts not previously reported, including two that narrow the effect of the pause.
The pause does not affect people progressing through a planned series of surgical procedures as part of a transition pathway, people who require treatment for complications, or people who have already begun a series of gender-affirming surgeries and need clinically necessary aftercare. When the service resumes, people will be considered in the order they held on the surgery waiting list. Both points came from the commissioner via Llais and neither appears in the original announcement.
On the governance question, Llais said it first became aware of the change when it was publicly announced, that it did not see the information that led to the decision before it was taken, and that it would have expected earlier engagement as the independent body representing people who use NHS Wales services. In answer to our questions, Llais confirmed it was formally notified on 1 September, four days after the public announcement and eight days after the decision, and that it had no role in the decision-making process. It also confirmed that it has not received the terms of reference for the independent review, and has been given only an outline of the proposed scope.
[Corrected, 8 September 2026. The final clause was wrong. Llais has since confirmed that the commissioner did not share the scope of this review with it at all, and that the earlier answer conflated this review with others. See the correction above.]
Two qualifications belong with that. Being formally notified on 1 September is not the same as being unaware until then, and Llais’s own statement makes clear it knew from the announcement. And patient-voice bodies are not ordinarily consulted on urgent clinical safety decisions; Llais represents rather than decides. The point is narrower: the commissioner’s own framework treats involvement of the citizen voice body as critical at the level at which service delivery is stopped, and the measure was applied a level below that.
The commissioner told Llais on 3 September that it is working to put in place the patient safety, quality assurance and clinical governance arrangements needed to resume the service as soon as possible. The Welsh Government said the following day that each relevant case will be reviewed. Those are not the same remedy, and it is not yet clear whether both are intended.
Llais is asking people whose care has been affected to share their experience, through its national survey or its local teams.
Update — 5 September 2026
On 4 September, after meeting the health minister and the deputy first minister, the NHS Wales Joint Commissioning Committee set out its reasoning publicly for the first time. This piece was published on 1 September, and parts of it are superseded.
The committee said that the proportion of Welsh patients progressing from referral to surgery, for some types of surgery, was significantly lower than in England; that in some cases patients did not meet the basic requirements for surgery, with body mass index arising as a factor; that there were concerns about whether wider health needs had been fully considered; and that some clinical professionals had raised concerns about whether parts of the referral assessment process had been carried out appropriately.
That is the specific concern this piece said the published record did not contain. It now does. It is also a more coherent account than the referral rate on its own: referrals made for patients who do not meet the surgical provider’s criteria would produce both a higher referral rate and a lower progression rate, from a single cause. Two figures, one explanation.
The Welsh Government said ministers sought and received assurances that the decision is a pause rather than a stop, that each relevant case will be reviewed, and that individuals will progress to surgery once the committee has assurances that appropriate clinical assessments are in place. Case-by-case review is what this piece said was the only thing capable of answering the question.
What this piece said about the governance record stands. The decision itself, the authority under which it was taken, and any equality impact assessment are still absent from the published record, and the measure taken still corresponds to a level of the committee’s own escalation framework above the one applied. A decision can be substantively right and still be taken without a recorded basis. Those are separate questions and only the second is still open.
Affected passages are marked in the text above. Nothing has been deleted.
Wording correction, 8 September 2026. The correction panel of 8 September originally paraphrased the commissioner as saying the review scope needed further shaping “before the process can be considered thorough and robust.” The source wording, relayed to us by Llais, was that it needed shaping “to ensure the process is thorough and robust.” The first implies the current state falls short; the second describes what proper scoping does. Only the second is supported, and the panel above now carries it.
Eden Openly publishes at four layers: opinion, evidence notes, evidence reviews, and primary sources. This is an opinion piece. It rests on published committee papers and public statements, and on no privileged information. It contains no case-level clinical detail because we hold none. An Evidence Note will follow once the confirmed minutes of the 24 August meeting are published and the correspondence is answered or is not.
Corrections: [email protected]
